Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen.
Cheong EJY, Nair PC, Neo RWY, Tu HT, Lin F, Chiong E, Esuvaranathan K, Fan H, Szmulewitz RZ, Peer CJ, Figg WD, Chai CLL, Miners JO, Chan ECY.
Cheong EJY, et al. Among authors: neo rwy.
J Pharmacol Exp Ther. 2020 Sep;374(3):438-451. doi: 10.1124/jpet.120.265868. Epub 2020 Jun 17.
J Pharmacol Exp Ther. 2020.
PMID: 32554434
Free PMC article.